MEDIPOST Co. Ltd (078160) - Net Assets

Latest as of September 2025: ₩265.17 Billion KRW ≈ $179.70 Million USD

Based on the latest financial reports, MEDIPOST Co. Ltd (078160) has net assets worth ₩265.17 Billion KRW (≈ $179.70 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩374.57 Billion ≈ $253.84 Million USD) and total liabilities (₩109.40 Billion ≈ $74.14 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 078160 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	₩265.17 Billion
% of Total Assets	70.79%
Annual Growth Rate	6.24%
5-Year Change	116.74%
10-Year Change	72.44%
Growth Volatility	25.37

MEDIPOST Co. Ltd - Net Assets Trend (2011–2024)

This chart illustrates how MEDIPOST Co. Ltd's net assets have evolved over time, based on quarterly financial data. See MEDIPOST Co. Ltd (078160) liquidity interval to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for MEDIPOST Co. Ltd (2011–2024)

The table below shows the annual net assets of MEDIPOST Co. Ltd from 2011 to 2024. For live valuation and market cap data, see MEDIPOST Co. Ltd (078160) market capitalisation.

Year	Net Assets	Change
2024-12-31	₩252.60 Billion ≈ $171.18 Million	-19.47%
2023-12-31	₩313.66 Billion ≈ $212.56 Million	+74.28%
2022-12-31	₩179.97 Billion ≈ $121.96 Million	+12.85%
2021-12-31	₩159.48 Billion ≈ $108.08 Million	+36.84%
2020-12-31	₩116.54 Billion ≈ $78.98 Million	+4.44%
2019-12-31	₩111.59 Billion ≈ $75.62 Million	-12.01%
2018-12-31	₩126.81 Billion ≈ $85.94 Million	+21.41%
2017-12-31	₩104.45 Billion ≈ $70.78 Million	-27.12%
2016-12-31	₩143.31 Billion ≈ $97.12 Million	-2.17%
2015-12-31	₩146.48 Billion ≈ $99.27 Million	+24.84%
2014-12-31	₩117.34 Billion ≈ $79.52 Million	-0.07%
2013-12-31	₩117.42 Billion ≈ $79.58 Million	+0.17%
2012-12-31	₩117.23 Billion ≈ $79.44 Million	+1.90%
2011-12-31	₩115.04 Billion ≈ $77.96 Million	--

Equity Component Analysis

This analysis shows how different components contribute to MEDIPOST Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 934.9% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Other Components	₩350.60 Billion	139.51%
Total Equity	₩251.31 Billion	100.00%

MEDIPOST Co. Ltd Competitors by Market Cap

The table below lists competitors of MEDIPOST Co. Ltd ranked by their market capitalization.

Company	Market Cap
Oneview Healthcare Plc AU:ONE	$105.83 Million
FitLife Brands, Inc. Common Stock NASDAQ:FTLF	$105.84 Million
Dyaco International Inc TW:1598	$105.85 Million
Greenheart Gold Inc. V:GHRT	$105.91 Million
Faraday Future Intelligent Electric Inc NASDAQ:FFIE	$105.77 Million
Argent JSE:ART	$105.76 Million
Namsun Alumini KO:008350	$105.76 Million
Noroo Paint KO:090350	$105.72 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in MEDIPOST Co. Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 311,554,525,920 to 251,310,495,620, a change of -60,244,030,300 (-19.3%).
Net loss of 62,524,995,360 reduced equity.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	₩-62.52 Billion	-24.88%
Other Changes	₩2.28 Billion	+0.91%
Total Change	₩-	-19.34%

Book Value vs Market Value Analysis

This analysis compares MEDIPOST Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.38x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has increased from 1.10x to 1.38x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	₩9258.61	₩10150.00	x
2017-12-31	₩6747.79	₩10150.00	x
2018-12-31	₩8182.15	₩10150.00	x
2019-12-31	₩7199.82	₩10150.00	x
2020-12-31	₩7519.53	₩10150.00	x
2021-12-31	₩9877.81	₩10150.00	x
2022-12-31	₩11147.01	₩10150.00	x
2023-12-31	₩9136.82	₩10150.00	x
2024-12-31	₩7370.07	₩10150.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently MEDIPOST Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -24.88%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -88.49%
• Asset Turnover: 0.17x
• Equity Multiplier: 1.65x
Recent ROE (-24.88%) is below the historical average (-2.56%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2011	3.85%	12.39%	0.27x	1.15x	₩-7.03 Billion
2012	1.46%	4.16%	0.30x	1.18x	₩-9.95 Billion
2013	0.86%	2.40%	0.28x	1.25x	₩-10.65 Billion
2014	-1.59%	-4.47%	0.22x	1.60x	₩-13.51 Billion
2015	1.90%	7.40%	0.21x	1.25x	₩-11.87 Billion
2016	-3.74%	-18.73%	0.16x	1.25x	₩-19.70 Billion
2017	-0.91%	-2.25%	0.29x	1.38x	₩-11.39 Billion
2018	-1.58%	-4.52%	0.25x	1.39x	₩-14.69 Billion
2019	-12.65%	-30.82%	0.21x	1.92x	₩-25.28 Billion
2020	-1.63%	-3.90%	0.22x	1.89x	₩-13.55 Billion
2021	-0.43%	-1.25%	0.22x	1.59x	₩-16.63 Billion
2022	1.71%	4.78%	0.16x	2.21x	₩-14.93 Billion
2023	1.87%	8.51%	0.15x	1.44x	₩-25.32 Billion
2024	-24.88%	-88.49%	0.17x	1.65x	₩-87.66 Billion

Industry Comparison

This section compares MEDIPOST Co. Ltd's net assets metrics with peer companies in the Biotechnology & Medical Research industry.

Industry Context

Industry: Biotechnology & Medical Research
Average net assets among peers: $57,410,940,738
Average return on equity (ROE) among peers: -4.78%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
MEDIPOST Co. Ltd (078160)	₩265.17 Billion	3.85%	0.41x	$105.79 Million
Macrogen Inc (038290)	$67.13 Billion	4.52%	0.73x	$91.68 Million
Panagene Inc (046210)	$76.04 Billion	-2.56%	0.44x	$33.71 Million
Cell Biotech Co. Ltd (049960)	$99.98 Billion	3.19%	0.05x	$83.34 Million
Bioneer Corporation (064550)	$30.61 Billion	-25.57%	1.68x	$114.71 Million
Biotoxtech Co. Ltd (086040)	$25.60 Billion	0.00%	0.81x	$24.12 Million
Peptron Inc (087010)	$45.10 Billion	-8.26%	0.59x	$2.25 Billion

About MEDIPOST Co. Ltd

KQ:078160 Korea Biotechnology & Medical Research

Market Cap

$105.79 Million

₩156.10 Billion KRW

Market Cap Rank

#19067 Global

#918 in Korea

Share Price

₩10150.00

Change (1 day)

-4.61%

52-Week Range

₩9390.00 - ₩28000.00

All Time High

₩72522.12